 |
Silibinin-C-2′,3-dihydrogensuccinate, disodium salt |
|---|---|
| Trade Name | Legalon Sil |
| Orphan Indication | Prevention of recurrent hepatitis C in liver transplant patients |
| USA Market Approval | USA |
| USA Designation Date | 2012-02-17 00:00:00 |
| Sponsor | Mylan Specialty LP;781 Chestnut Ridge Road, P. O. Box 4310;Morgantown, West Virginia, 26505 |
